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Abstract
Human respiratory syncytial virus (HRSV) is a leading cause of severe lower respiratory
tract infection in children under five years of age. IL-17 and Th17 responses are increased
in children infected with HRSV and have been implicated in both protective and pathogenic
roles during infection. Bovine RSV (BRSV) is genetically closely related to HRSV and is a
leading cause of severe respiratory infections in young cattle. While BRSV infection in the
calf parallels many aspects of human infection with HRSV, IL-17 and Th17 responses have
not been studied in the bovine. Here we demonstrate that calves infected with BRSV
express significant levels of IL-17, IL-21 and IL-22; and both CD4 T cells and γδ T cells con-
tribute to this response. In addition to causing significant morbidity from uncomplicated
infections, BRSV infection also contributes to the development of bovine respiratory dis-
ease complex (BRDC), a leading cause of morbidity in both beef and dairy cattle. BRDC is
caused by a primary viral infection, followed by secondary bacterial pneumonia by patho-
gens such asMannheimia haemolytica. Here, we demonstrate that in vivo infection withM.
haemolytica results in increased expression of IL-17, IL-21 and IL-22. We have also devel-
oped an in vitromodel of BRDC and show that co-infection of PBMC with BRSV followed by
M. haemolytica leads to significantly exacerbated IL-17 production, which is primarily medi-
ated by IL-17-producing γδ T cells. Together, our results demonstrate that calves, like
humans, mount a robust IL-17 response during RSV infection; and suggest a previously
unrecognized role for IL-17 and γδ T cells in the pathogenesis of BRDC.
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Introduction
Human respiratory syncytial virus (HRSV) is a leading cause of acute lower respiratory tract
disease in human infants worldwide. It is estimated that over 33 million children under the age
of 5 years old contract the disease, resulting in over 3 million hospitalizations and nearly
200,000 deaths [1]. Currently, no licensed vaccine is available for HRSV.
Bovine respiratory syncytial virus (BRSV) is genetically and antigenically closely related to
HRSV. BRSV infection is among the leading causes of lower respiratory tract infections in
young calves [2–4]. BRSV infection in the calf parallels many features of HRSV infection in
humans, including age-dependent susceptibility, microscopic lesions and innate and adaptive
immune responses [3, 5, 6]. BRSV infection in neonatal calves represents a fully permissive,
natural host-pathogen interaction that closely mimics HRSV infection in human infants. Thus,
BRSV infection is increasingly recognized as an excellent model for studying disease pathogen-
esis and immunity to HRSV infection in children, as well as for pre-clinical testing of novel vac-
cines and therapeutics [3, 5, 6].
In addition to causing morbidity in calves due to uncomplicated infections, BRSV is an
important contributing factor in the development of bovine respiratory disease complex
(BRDC), a multifactorial disease condition affecting cattle in all stages and categories of pro-
duction [2–4, 7]. The etiology of BRDC is not well understood but usually affects animals that
are stressed due to weaning, shipping or comingling, and is a result of co-infections by multiple
viral and bacterial agents, including BRSV,Mannheimia haemolytica, Pasteurella multocida
andHistophilus somni [8–13]. BRDC is the leading cause of morbidity and mortality among
feedlot cattle and is the most common cause of weaned dairy heifer mortality [3, 4]. Economic
costs to the cattle industry due to BRDC have been estimated as high as $3 billion annually due
to death losses, reduced performance and costs of vaccinations and treatment modalities [14].
Features of BRDC include significant pro-inflammatory cytokine production and broncho-
pneumonia including severe neutrophilia in the lungs. The mechanisms of immune suppres-
sion and disease pathogenesis contributing to the development of BRDC remain unclear.
Hallmarks of severe RSV infection in infants and BRSV infection in calves include rapid
neutrophil infiltration, excessive mucus production and a delayed virus-specific CD8 T cell
response [15–17]. Strong expression of Th2 cytokines such as IL-13 are commonly implicated
in disease pathogenesis [18]. However, recent results from humans and mice have suggested
that IL-17-dependent immune activation may also be a critical factor in the response to RSV
infection [19–23].
IL-17 is a pro-inflammatory cytokine that is primarily produced by activated γδ T cells and
CD4+ T cells, termed Th17 cells [24]. The main effector cytokines associated with Th17
immunity are IL-17A, (IL-17), IL-17F, IL-21 and IL-22. IL-17, like IFNγ, is a “master regula-
tor” of downstream cytokine and chemokine responses. Expression of IL-17 stimulates stro-
mal and epithelial cells to produce chemokines such as CXCL1, CCL20, IL-6, and most
importantly, IL-8, leading to recruitment and activation of neutrophils and monocytes [25].
While critical for protection from several types of extracellular bacterial and fungal infections,
the role of IL-17 and Th17 cells in immunity against intracellular pathogens such as RSV
remains less clear. Faber et al. reported significantly lower levels of IL-17 in the bronchoalveo-
lar lavage (BAL) of severely ill, pediatric RSV patients compared to less severe cases [19]. Sim-
ilarly, a study by Larranaga et al. revealed higher plasma levels of IL-17 in infants with
moderate RSV infection compared to those with severe disease [26]. In contrast, Mukherjee
et al. observed increased levels of IL-17 in tracheal aspirates from severely ill infants compared
to healthy controls [21]. Mice deficient in STAT1 [27] or CCR7 [28] display increased pathol-
ogy in the lungs that is attributed to increased production of IL-17; and animals deficient in
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IL-17 display significantly reduced mucus production and increased CD8 T cell responses in
the lungs during primary RSV infection [21]. The role of IL-17 in RSV-associated allergic sen-
sitization appears similarly complex, with reports that this cytokine both prevents [22] and
promotes [21] airway reactivity.
Here, we report for the first time that calves infected with BRSV express increased levels of
IL-17 in the lungs, and develop virus-specific IL-17 producing lymphocytes in the blood by day
7 after infection. Similarly, calves vaccinated with a live-attenuated strain of BRSV mount
virus-specific IL-17 responses in the blood. Both CD4 and γδ T lymphocytes have the capacity
to secrete IL-17 in response to viral infection. Using an in vitro co-infection model of BRSV
andM. haemolytica to model BRDC, we further demonstrate that BRSV-induced expression of
IL-17 is significantly exacerbated in the presence of secondary bacterial exposure toM. haemo-
lytica, suggesting a mechanism that may be contributing to neutrophilia in the lungs of calves
with BRDC. Interestingly, this exacerbated IL-17 production appears primarily mediated by γδ
T cells, as depletion of these cells from culture ablates the effect. Together, our results demon-
strate that calves, like humans and mice, mount a significant IL-17 response during acute
BRSV infection and suggest a possible role for γδ T lymphocytes in contributing to BRDC-
associated immunopathology in the calf.
Materials and Methods
Animals
BRSV infected animals. Lung samples and peripheral blood samples were collected over 3
experiments from a total of 16, 4–6 week old Holstein calves. Eight calves were infected with
BRSV Strain 375 via aerosol inoculation as previously described [29, 30]. Eight uninfected, age-
matched calves served as negative controls. All animals were housed in a climate-controlled,
biosafety level-2 facility at the National Animal Disease Center in Ames, IA. Peripheral blood
was collected via the jugular vein on day 0 prior to infection, and on day 3 and 7 post infection.
Calves were monitored daily following experimental infection. Clinical signs were evaluated
including rectal temperature, evidence of ocular or nasal discharge, cough, dyspnea, and appe-
tite. The animal care protocol included provisions for a humane endpoint as determined by the
discretion of the attending clinical veterinarian. No animals died or required euthanasia prior
to the experimental endpoint. Methods to minimize pain and distress included the avoidance
of prolonged restraint and the inclusion of euthanasia as an intervention strategy. Fundamental
to the relief of pain and distress is the ability to recognize clinical signs of RSV in calves. The
investigator provides assurance that any unrelieved pain and distress occurred only for the
minimum time necessary to achieve study objectives and was based on sound scientific ratio-
nale. Calves were euthanized by barbiturate overdose on day 7-post infection. Lungs were
removed and samples from representative gross lesion and nonlesion tissue collected from
each calf and stored in RNAlater (Invitrogen, Life Technologies).
M. haemolytica infected animals. Lung samples were collected from a total of 8, 6-month
old castrated male Holstein calves. All calves were housed at the Large Animal Research Facility
at Kansas State University. Four calves were infected via endoscope-guided challenge with
3x108 CFU/mL of a field strain ofM. haemolytica serotype A1 previously isolated from the
lung of a bovine with BRDC [31, 32]. Protocols for growing and administering the challenge
inoculum have been previously described [31, 32]. Four calves served as uninfected controls
and received only PBS via endoscope-guided administration. Calves were monitored twice
daily following experimental infection. Clinical signs were evaluated including rectal tempera-
ture, evidence of ocular or nasal discharge, cough, dyspnea, and appetite. The animal care pro-
tocol included provisions for a humane endpoint as determined by the discretion of the
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attending clinical veterinarian. Methods to minimize pain and distress included the avoidance
of prolonged restraint and the inclusion of euthanasia as an intervention strategy. No animals
died or required euthanasia prior to the experimental endpoint. Calves were euthanized by cap-
tive bolt on day 3-post infection. Lungs were removed and samples from representative gross
lesion and non-lesion tissue collected from each calf and stored in RNAlater.
BRSV vaccinated animals. PBMC were collected from a total of 16 female adult Holstein
cows housed at the dairy facility at the National Animal Disease Center in Ames, IA (n = 8)
or the Kansas State Dairy in Manhattan, KS (n = 8). All cows were on an annual vaccination
program and received a multivalent commercial vaccine containing live attenuated BRSV
(BoviShield Gold FP5) within 4–12 weeks of inclusion in the study. No experimental end-
point was established for these animals, as they were healthy and were not experimentally
infected. All provisions to minimize pain and distress were used including phlebotomy by
experienced handlers and avoidance of prolonged restraint. All animals tested positive for
antibodies to BRSV (titer of 1:32–1:128), and positive for BRSV-specific CD4 T cell responses
prior to enrollment into the study. Six cows that were not on the annual vaccination program
due to inclusion in another study were used as nonvaccinated controls. Control cows were
also housed at the Kansas State University Dairy in Manhattan, KS. These animals had a
BRSV titer of 1:8–1:64, but had no detectable BRSV-specific CD4 T cell responses as mea-
sured by T cell proliferation assays.
All animal studies were conducted in strict accordance with federal and institutional guide-
lines and were approved by the National Animal Disease Center Institutional Animal Care and
Use Committee or the Kansas State University Institutional Animal Care and Use Committee,
as appropriate.
Peripheral blood collection and mononuclear cell preparation
Mononuclear cells were isolated by density centrifugation of peripheral blood collected from
the jugular vein into 2x acid citrate dextrose. Contaminating red blood cells were removed
using hypotonic lysis. Cells were washed and resuspended in complete RPMI (cRPMI) as previ-
ously described [30].
CD4 T cells and γδ T cells were enriched from PBMC using Magnetic Activated Cell Sorting
(MACS) as previously published [33]. Briefly, PBMC were labeled with 10 μg/mL mouse anti-
bovine CD4 (clone ILA11A) or 10 μg/mL mouse anti-bovine γδ T cell receptor (Clone
GB21A), both fromWashington State Monoclonal Antibody Center (Pullman, WA). Cells
were then labeled with anti-mouse IgG2A+B magnetic beads (Miltenyi Biotech) and purified
by positive sorting per manufacturer’s instructions.
WC1 expressing subsets of γδ T cells were isolated by FACS sorting as previously described
[30, 33]. PBMC were labeled with mouse anti-bovine WC1.1 (Clone BAG25A), mouse anti-
bovine WC1.2 (Clone CACTB32A) and mouse anti-bovine γδ T cell receptor (Clone
GB21A), all fromWashington State Monoclonal Antibody Center (Pullman, WA). Cells were
then labeled with anti-mouse IgG1-AF488, anti-mouse IgM-PE and anti-mouse IgG2b-
AF647 secondary antibodies (Invitrogen, Life Technologies). Cells were sort purified based
upon their expression of the γδ T cell receptor and WC1.1, WC1.2 or lack of WC1 expression.
Subsets were sorted to > 90% purity using a BD FACS Aria Cell Sorting System (BD Biosci-
ences, San Jose, CA).
Monocytes were isolated by plastic adherence as previously described [30, 33]. Briefly,
PBMC were suspended in cRPMI and allowed to adhere to plastic Petri dishes for 2 hr at 37°C.
Non-adherent cells were removed by washing with warm cRPMI. Adherent cells were collected
by washing with ice-cold PBS and gentle scraping.
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In vitro cell stimulation
PBMC or MACS purified T lymphocytes were plated at a concentration of 4x106 cells/mL in
cRPMI (100 μl/well) in sterile, round-bottom, 96-well tissue-culture-treated plates (BD Biosci-
ences). For experiments requiring antigen-presenting cells (APC), monocytes were plated at a
ratio of 1:5 with purified CD4 or γδ T cells. In some experiments, cells were labeled with Cell
Trace Violet per manufacturer’s recommendations (Invitrogen, Life Technologies) prior to
being placed in culture. For in vitro re-stimulation with BRSV, cells were incubated at a 0.1
multiplicity of infection (MOI) with BRSV Strain 375 for 90 min at 37°, washed once and
resuspended in cRPMI for the remaining incubation period. For experiments using heat-killed
BRSV, virus stock was inactivated for 30 minutes at 56°C, then 50 μl added to the cultures
(final volume of 200 μl/well).
For in vitro BRDC experiments, cells were infected with BRSV Strain 375 as above. Four
hours later,M. haemolytica strain D153, serotype A1 or Pastuerella multocida strain P1062,
serotype A3 was suspended in antibiotic-free RPMI and added to the cell cultures at ~0.1 MOI
as determined by spectrophotometric growth curves. After 3–4 hours, cells were resuspended
in antibiotic-containing cRPMI to prevent bacterial overgrowth. Importantly, we performed
dose titrations to determine the optimal concentration ofM. haemolytica to add to our cul-
tures. The addition of higher concentrations ofM. haemolytica resulted in significant cell
death, likely a result of the action of leukotoxin [34–36], while an MOI of 0.5 or less did not
induce significantly increased cell death over uninfected cultures (not shown). Heat-inactivated
M. haemolytica D153 was prepared by suspending bacteria in antibiotic-free RPMI at approxi-
mately 0.1 MOI, then boiling for 15 minutes. InactivatedM. haemolytica was then added to
PBMC cultures for 3–4 hours, followed by centrifugation and a media change to antibiotic-
containing cRPMI as above.
At the indicated times (24 hours or 6 days of culture), PBMC, CD4 or γδ T cells were pel-
leted by centrifugation and cell culture supernatants were collected and stored at −80°C. Cell
pellets were then lysed with Buffer RLT (Qiagen, Valencia, CA) containing 2-mercaptoethanol
and stored at −80°C.
Real-time PCR
RNA was isolated from lung tissue samples using Trizol Reagent (Invitrogen, Life Technolo-
gies) according to manufacturer’s instructions. The RNA concentration in each sample was
determined using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Wilmington, DE).
RNA (300 ng per sample) was DNase-treated and cDNA synthesized using random primers
and Superscript III Reverse Transcriptase according to the manufacturer's instructions (Invi-
trogen, Life Technologies).
For PBMC, purified T cell populations and bovine turbinates (BT), RNA was extracted
using the RNeasy Mini RNA Isolation kit (Qiagen) according to manufacturer's instructions.
Contaminating genomic DNA was removed using the RNase-Free DNase digestion set (Qia-
gen) as per manufacturer's instructions. Total eluted RNA was reverse transcribed into cDNA
using Superscript III Reverse Transcriptase and Random Primers following the manufacturer's
instructions.
Quantitative real-time PCR (qPCR) was performed using Power SYBR Green PCRMaster
Mix (Applied Biosystems, Carlsbad, CA). Forward and reverse primers used in the study are
listed in Table 1. Reactions were performed on a 7300 Real-Time PCR System (Applied Biosys-
tems, Life Technologies, Carlsbad, CA) or an Mx3005P qPCR System (Agilent Technologies,
Santa Clara, CA). The following amplification conditions were used: 2 min at 50°, 10 min at
95°, 40 cycles of 15 seconds at 95° and 1 min at 60°, and a dissociation step (15 seconds at 95°,
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1 min at 60°, 15 seconds at 95°, 15 seconds at 60°). Relative gene expression was determined
using the 2-ΔΔCt method with RPS9 as the reference housekeeping gene.
IL-17 ELISA
The Bovine IL-17A VetSet ELISA Development kit was purchased from Kingfisher Biotech,
Inc. (St. Paul, MN). ELISAs were performed using cell culture supernatants according to manu-
facturer’s instructions.
Stimulation of BT
BT cells were cultured in cMEM, plated in 96-well, flat-bottom tissue-culture-treated plates
and grown to confluence overnight at 37°C. Cell culture supernatants from day 6 stimulated
PBMC, CD4 or γδ T cell culture supernatants were diluted 1:2 with cMEM, and then added to
the BT cells. Cells were incubated overnight, then lysed with Buffer RLT (Qiagen, Valencia,
CA) containing 2-mercaptoethanol and stored at −80°C until RNA extraction.
Statistical Analysis
ΔΔCt values were used in the statistical analysis of relative gene expression. ΔΔCt values were
transformed (2-ΔΔCt) and are shown as expression relative to uninfected or unstimulated con-
trol samples, as appropriate. [40]
Statistical analyses were performed using Prism v6.0f software (Graphpad Software, Inc.)
Statistical comparisons were performed using a two-tailed Student’s t-test when comparing
control to infected or stimulated samples; or a one-way ANOVA with Bonferri post-test analy-
sis, when comparing multiple treatment conditions (in vitro BRDC studies).
Results
IL-17 response in the lungs and peripheral blood of calves infected with
bovine RSV
IL-17 expression is increased in mice and humans with acute RSV infection [20–23, 41], but
has not been studied in calves with acute BRSV infection. To this end, neonatal Holstein calves
Table 1. Primers used for qPCR.
Gene (alternate name) Accession number Strand Sequence (5’-3’) Reference
IL17 NM_001008412 Forward CACAGCATGTGAGGGTCAAAC [37]
Reverse GGTGGAGCGCTTGTGATAAT
IL-21 NM_198832 Forward GTGGCCCATAAGTCAAGCTC [38]
Reverse CGCTCACAGTGTCTCTTTAC
IL-22 NM_001098379 Forward GACTGTGGAGTTTGGCTCCCCCTTTTC [38]
Reverse GAGATTAAAGTCATTGGAGAACTGAAC
IL-8 X78306 Forward AAGCTGGCTGTTGCTCTC [29]
Reverse GGCATCAGAAGTTCTGTACTC
MUC5AC BN001491 Forward CAGACCCTCCACCTTCTTCA [39]
Reverse GGTCCTCGAAGCTGTTCTTG
MUC5B BN0011492 Forward TCTACCTGACCGTGGAGACC [39]
Reverse GTTGATGATGCTGCACTGCT
RPS9 NM_001101152.1 Forward CGCCTCGACCAAGAGCTGAAG [29]
Reverse CCTCCAGACCTCACGTTTGTTCC
doi:10.1371/journal.pone.0151083.t001
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were infected with BRSV strain 375 via aerosol inoculation. On day 7-post infection, lung sam-
ples were analyzed by qPCR for expression of IL-17 and the Th17-associated cytokines IL-21
and IL-22. As seen in Fig 1, BRSV infection resulted in significantly increased expression of IL-
17 and IL-22 in the lungs of infected calves (Fig 1A). IL-21 expression was not significantly
increased in pneumonic lung at this time.
IL-17 promotes increased production of the pro-inflammatory chemokine, IL-8. IL-8 is
increased in humans with RSV [42, 43] and we have previously demonstrated that IL-8 is upre-
gulated in the lungs of calves with BRSV [29]. In agreement with these previous reports, IL-8
expression was significantly increased in the lung lesions of calves infected with BRSV com-
pared to lungs from uninfected control calves (Fig 1B).
To determine if BRSV infection induced the development of systemic Th17 responses,
peripheral blood was collected from control and BRSV-infected calves on day 7-post infection.
PBMC were restimulated with heat-killed BRSV antigen for 24 hours (Fig 1C) and examined
by qPCR for expression of IL-17. PBMC from calves with acute BRSV infection expressed sig-
nificantly increased levels of IL-17 in recall response to BRSV infection. Importantly, signifi-
cant IL-17 expression was not observed in PBMC collected from the calves on day 0 or 3-post
infection (data not shown). PBMC were also stimulated with heat-killed BRSV antigen for 6
days and culture supernatants analyzed by ELISA. In agreement with the qPCR results, PBMC
Fig 1. IL-17 and Th17 responses in the lungs and peripheral blood of calves infected with BRSV.Calves (n = 8) were infected via aerosol inoculation
with BRSV Strain 375 (RSV) as described in Materials and Methods. Control calves remained uninfected (n = 8). On day 7 post-infection, the animals were
sacrificed and the lungs analyzed by qPCR for expression of IL-17, IL-21 and IL-22 (A) and IL-8 (B). In separate experiments, PBMCwere isolated from
control (n = 8) and BRSV infected calves (n = 8) on day 7-post infection. PBMCwere stimulated with BRSV for 24 hours and then analyzed for expression of
IL-17 by qPCR (C); or for 6 days and then cell culture supernatants were analyzed by ELISA for expression of IL-17 (D). For qPCR analysis, results were
normalized to the housekeeping gene RPS-9, and expressed relative to samples from uninfected control calves. Results were pooled from a total of three
independent experiments. Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g001
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from infected, but not control calves secreted significantly increased concentrations of IL-17 in
recall response to BRSV antigen (Fig 1D).
IL-17 response in the peripheral blood of calves vaccinated with live-
attenuated BRSV
We next chose to determine if BRSV vaccination also induces the development of virus-specific
IL-17 responses. PBMC were collected from adult Holstein cows within 4–12 weeks of
Fig 2. IL-17 and Th17 responses from BRSV vaccinated cattle. Peripheral blood was collected from cows receiving annual vaccinations with a multivalent
vaccine containing live-attenuated BRSV (n = 8), or from control cows that were not included in the vaccination program due to inclusion in another study
(n = 6). PMBC were isolated and stimulated with BRSV for 24 hours or 6 days, as in Fig 1. RNA was isolated from the cells and analyzed by qPCR for
expression of IL-17 (A, left panel), IL-21 (B) and IL-22 (C). Cell culture supernatants were also analyzed by ELISA for IL-17 (A, right panel). For qPCR
analysis, results were normalized to the housekeeping gene RPS-9, and expressed relative to unstimulated control samples. Results were pooled from two
independent experiments. Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g002
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receiving an annual booster of live, attenuated BRSV vaccine. Peripheral blood was also col-
lected from control cows that were not included in the annual vaccination program due to
inclusion in another study. PBMC from both groups of animals were stimulated with heat-
killed BRSV strain 375 and assessed by qPCR 24 hours later for expression of IL-17. In agree-
ment with our results from calves with acute BRSV infection, cells from BRSV vaccinated ani-
mals produced virus-specific IL-17 as measured by qPCR (Fig 2A) and by ELISA (Fig 2B).
Similar to our results from BRSV infected calves, PBMC from vaccinated cows also expressed
increased levels of IL-21 and IL-22 in recall responses to BRSV antigen (Fig 2).
Severe RSV infection in humans is associated with increased neutrophil infiltration and
increased mucus production. IL-17 reportedly increases expression of IL-8, a critical neutrophil
chemoattractant, and the genes encoding mucins, MUC5AC and MUC5B [24]. To confirm
that IL-17 and the Th17 associated cytokines induced by BRSV displayed similar activity in the
bovine, we treated BT cells for 24 hours with supernatants collected from BRSV antigen-stimu-
lated cultures. BT cells were then analyzed by qPCR for expression of IL-8 (Fig 3A), MUC5AC
(Fig 3B) and MUC5B (Fig 3C). As seen in Fig 3, cell culture supernatants from non-vaccinated
cows that were stimulated with BRSV induced only minor expression of IL-8, MUC5B and
MUC5AC by BT, while stimulated supernatants from vaccinated calves induced increased
expression of all three target genes by BT cells.
CD4 and γδ T cells produce IL-17 in response to BRSV
Both CD4 T cells and γδ T cells have the capacity to produce IL-17 in response to RSV infection
in humans and mice [24]. Therefore, we next chose to determine which T cell subsets from cat-
tle produce IL-17 in recall response to BRSV stimulation. PBMC from BRSV vaccinated cattle
were labeled with CellTrace Violet, then cultured for 6 days in the presence or absence of heat-
killed BRSV. CD4 T cells and γδ T cells were then analyzed by flow cytometry for BRSV-specific
proliferation as measured by CellTrace Violet dilution. As seen in Fig 4A–4C, both CD4 T cells
and γδ T cells from vaccinated cows proliferate in specific response to stimulation with BRSV
antigen. Not surprisingly, we observed higher levels of non-specific proliferation by γδ T cells
from control, non-vaccinated cows; however, BRSV-induced proliferation was still significantly
Fig 3. Cell culture supernatants from BRSV stimulated PBMC induce expression of IL-8, MUC5B and MUC5AC by BT cells. PBMC from control
(nonvaccinated) and BRSV vaccinated cows were isolated and stimulated with heat-killed BRSV for 6 days as in Fig 2. Cell culture supernatants were then
diluted 1:1 in cMEM and added to confluent BT cells in 96 well plates for 24 hours. RNA was the isolated from the BT and analyzed by qPCR for expression of
IL-8 (A), MUC5B (B) and MUC5AC (C). For qPCR analysis, results were normalized to the housekeeping gene RPS-9, and expressed relative to
unstimulated control samples. Results were pooled from two independent experiments. Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g003
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increased above background levels (Fig 4C). Unfortunately, an antibody is not available for
intracellular cytokine staining of bovine IL-17. Therefore, CD4 T cells and γδ T cells were puri-
fied by MACS and cultured with autologous APC in the presence or absence of BRSV antigen
for 6 days. Cell culture supernatants were then analyzed by ELISA to determine concentrations
of IL-17. As seen in Fig 4D, both CD4 T cells and γδ T cells secrete IL-17 in specific response to
BRSV antigen. γδ T cell production of non-specific IL-17 was increased compared to CD4 T
cells, but stimulation with BRSV antigen resulted in a significant increase in virus-specific IL-17
production by purified γδ T cells. Importantly, we observed similar IL-17 production when ana-
lyzing CD4 and γδ T cells isolated from peripheral blood of BRSV infected calves (Fig 4E).
In cattle, γδ T cells are phenotypically and functionally divided into subsets based upon
their expression of WC1. We have previously demonstrated that WC1neg, WC1.1+ and
WC1.2+ γδ T cell subsets respond to BRSV infection, and the subsets differ in their response to
virus with regards to inflammatory chemokine expression, IFNγ production and production of
regulatory cytokines such as IL-10 [30]. We next chose to determine the contribution of indi-
vidual WC1-expressing subsets in production of IL-17 during the response to BRSV. γδ T cells
Fig 4. Both CD4 T cells and γδ T cells produce IL-17 in response to BRSV. PBMCwere isolated from control or BRSV vaccinated cows and labeled with
Cell Trace Violet. Cells were then cultured for 6 days with BRSV. On day 6, CD4 T cells (A) and γδ T cells (B) were analyzed for virus-specific proliferation as
measured by Cell Trace Violet dilution. Representative flow plots are shown in A and B. Aggregate results are shown in C. (D) CD4 T cells and γδ T cells from
BRSV vaccinated or nonvaccinated animals were isolated by MACS and cultured in the presence of autologous APC ± BRSV. After 6 days, cell culture
supernatants were analyzed by ELISA for IL-17. (E) CD4 T cells and γδ T cells were MACS purified from peripheral blood of calves infected or not with BRSV
strain 375 for 7 days. Purified cells were cultured in the presence of autologous APC ± BRSV. After 6 days, cell culture supernatants were analyzed by ELISA
for IL-17. For A-C, background levels of proliferation were subtracted and results are presented as change over mock. Results are pooled from two
independent experiments. Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g004
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were FACS purified into subsets based upon their expression of the γδ T cell receptor and
WC1.1, WC1.2 or lack of WC1 as previously described [30, 33]. Cells were cultured as in Fig 4
and then supernatants were assessed for concentrations of IL-17 by ELISA. As seen in Fig 5A,
WC1.1+ γδ T cells secreted significant levels of IL-17 in response to BRSV antigen, while nei-
ther WC1.2+ nor WC1neg subsets produced IL-17, suggesting the WC1.1 subset may be the pri-
mary γδ T cell-derived source of IL-17 during BRSV infection in the calf. Stimulation of BT
cells with culture supernatants from all three subsets of purified γδ T cell subsets resulted in an
increase in IL-8 expression (Fig 5B).
IL-17 expression in the lungs duringM. haemolytica infection
M. haemolytica is the predominant bacterial isolate recovered from cases of bovine pneumonia
and the leading cause of direct economic loss from BRDC in the United States [44]. IL-8 is
upregulated in the lungs ofM. haemolytica infected cattle [45, 46], and significant numbers of
neutrophils are recruited to the lungs following infection, resulting in the exacerbated inflam-
mation and tissue damage typical of BRDC [8, 34]. We next determined if IL-17 is contributing
to this increase in IL-8 production and neutrophil recruitment duringM. haemolytica infec-
tion. To this end, cattle were infected withM. haemolytica via endoscope-guided inoculation.
On day 3 after inoculation, animals were sacrificed and their lungs examined by qPCR for
expression of IL-17. As seen in Fig 6A,M. haemolytica infection results in increased expression
of IL-17, IL-22 and IL-23 in the lungs by day 3 after infection. In agreement with previous stud-
ies [45, 46], we also observed significantly increased expression of IL-8 in lung tissue fromM.
haemolytica infected calves compared to controls (Fig 6B).
In vitro infection with BRSV andM. haemolytica induces exacerbated
production of IL-17
Primary BRSV infection is a significant factor promoting the development of secondary bacterial
pneumonia caused by pathogens such asM. haemolytica. We are interested in determining
Fig 5. WC1.1+ γδ T cells produce IL-17 in response to BRSV. γδ T cells were purified from the peripheral blood of BRSV vaccinated or control animals by
FACS based upon their expression of the γδ T cell receptor and either expression of WC1.1, WC1.2 or lack of WC1. Cells were cultured in the presence of
autologous APC ± BRSV for 6 days. Cell culture supernatants were then analyzed by ELISA for IL-17. (B) Cell culture supernatants from (A) were also diluted
1:1 and added to BT cells for 24 hours. After 24 hours, BT were analyzed by qPCR for expression of IL-8. For qPCR analysis, results were normalized to the
housekeeping gene RPS-9, and expressed relative to unstimulated control samples. Results are pooled from two independent experiments. Data represent
means ± SEM.
doi:10.1371/journal.pone.0151083.g005
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mechanisms of immunity that predispose an animal to the development of BRDC. IL-17 plays a
critical role in neutrophil recruitment and inflammation, and neutrophilia in the lungs is a trait
characteristic of severe pasteruellosis in calves with BRDC [45]. Therefore, we chose to deter-
mine the effect of secondary bacterial exposure on IL-17 expression and its possible role in the
development of exacerbated bacterial pneumonia. To this end, we developed an in vitromodel
of BRDC. PBMC were infected with BRSV, followed by exposure to liveM. haemolytica, mim-
icking a situation that may occur in the lungs, where T lymphocytes recruited to control BRSV
infection are exposed toM. haemolytica during secondary bacterial infection. In Fig 7, PBMC
were infected with 0.1 MOI of BRSV strain 375 for 6 hours, thenM. haemolytica strain D153
was added to the cultures at an MOI of 0.1. Cells and bacteria were incubated for 4 hours in anti-
biotic free media, then antibiotics were added to control possible bacterial overgrowth. Cells
were stimulated for 18 hours and then analyzed by rtPCR, and were also cultured for 6 days and
supernatants measured by ELISA.M. haemolytica produces a potent leukotoxin that can induce
rapid cell death in activated bovine PBMC [34–36]. Thus, dose titration experiments were per-
formed to determine the optimal dose ofM. haemolytica to add that did not induce significantly
increased cell death in our PBMC cultures. Doses ofM. haemolytica above 0.5 MOI induced sig-
nificantly increased cell death in our PBMC coinfection cultures (data not shown), thus we
selected an MOI of 0.1. As seen in Fig 7A, cells exposed to either BRSV alone orM. haemolytica
alone secreted IL-17. However, IL-17 was significantly increased in the presence of both BRSV
andM. haemolytica. A similar exacerbation of IL-21 expression was also observed in the pres-
ence of both BRSV andM. haemolytica, but not following stimulation with either pathogen sin-
gly (Fig 7B). In contrast, expression of IL-22 was not increased following exposure to both BRSV
andM. haemolytica (Fig 7C). ELISA for IL-17 protein in day 6 culture supernatants confirmed
our qPCR results, demonstrating increased production of IL-17 in response to BRSV orM. hae-
molytica alone, but significantly exacerbated production in response to the pathogens together
(Fig 7D). Addition of the stimulated cell supernatants to BT cells as in Fig 3, also resulted in sig-
nificantly increased production of IL-8 (Fig 7E). This suggests that the increased production of
IL-17 during co-infections may significantly alter inflammatory cytokine production by epithe-
lial and stromal cells in the lungs, leading to the severe neutrophilia that is a hallmark of the
BRDC phenotype (Fig 7). Interestingly, a similar result is not observed in response to heat-inac-
tivatedM. haemolytica (Fig 8A) or in response to purifiedM. haemolytica LPS (Fig 8B).
Fig 6. M. haemolytica infection induces IL-17 and Th17 cytokine production. Calves (n = 4) were infected with a field strain ofM. haemolytica via
endoscope-guided inoculation as described in Materials and Methods. Control calves were sham inoculated (n = 4). On day 3 after infection, animals were
sacrificed and their lungs analyzed by qPCR for expression of IL-17, IL-21 and IL-22 (A); and for expression of IL-8 (B). Results were normalized to the
housekeeping gene RPS-9, and expressed relative to samples from uninfected control calves. Results are pooled from one experiment. Data represent
means ± SEM.
doi:10.1371/journal.pone.0151083.g006
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Pasteruerella multocida is also a known cause of BRDC in young calves. LikeM. haemolytica
infection, pathogenesis of P.multocida pneumonia includes severe neutrophilia in the lungs
[9]. We next determined if co-infection with P.multocida results in a similar exacerbation of
IL-17. Interestingly, although P.multocida alone promotes IL-17 production by bovine PBMC,
co-culturing of PBMC with P.multocida and BRSV together did not result in the same
enhanced IL-17 phenotype that was observed in response toM. haemolytica (Fig 8B).
To determine which cells were responsible for the exacerbated production of IL-17, we next
conducted depletion experiments. γδ T cells were depleted from the cultures by MACS, prior
to BRSV/M. haemolytica co-infection. As seen in Fig 8D, depletion of γδ T cells resulted in
slight, but not significant reductions in IL-17 production in cultures exposed to BRSV orM.
haemolytica individually. However, depletion of γδ T cells significantly reduced the exacer-
bated production of IL-17 in co-infected cultures (Fig 8D). Depletion of CD4 T cells from the
cultures yielded an overall reduction in IL-17 production in both singly and co-infected
Fig 7. In vitro infection with BRSV andM. haemolytica results in exacerbated IL-17 production. PBMC from BRSV vaccinated cows were stimulated
with BRSV for 6 hours, then cultured with 0.1 MOIM. haemolytica in antibiotic free media for 4 hours. After four hours, antibiotics were added, and then
incubations were continued for 18 hours (A-C) or 6 days (D and E). Control cultures were included that received neither pathogen, BRSV alone orM.
haemolytica alone. (A-C) Cells were analyzed by qPCR for expression of IL-17 (A), IL-21 (B) and IL-22 (C). Cell culture supernatants from day 6 were
analyzed by ELISA for IL-17 (D) and were diluted 1:1 and added to BT for 24 hours (E). BT were analyzed by qPCR for expression of IL-8 after overnight
stimulation as in Fig 3. Results in A-C are pooled from three independent experiments with n = 12. Results in D and E are from two experiments with n = 8.
Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g007
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cultures, but did not alter the exacerbated phenotype observed following exposure to both
pathogens (not shown). Together, our results suggest that γδ T cells are a significant source of
IL-17 during in vitro virus/bacterial coinfections, suggesting γδ T cell derived IL-17 may also
be important in the pathogenesis of BRDC in the calf.
Discussion
We demonstrate here for the first time that neonatal calves infected with BRSV mount a robust
IL-17 response in the lungs and peripheral blood. Both CD4 and γδ T cells are a significant
source of IL-17 in recall responses to BRSV antigen. Similarly, both CD4 T cells and γδ T cells
in rodents and humans contribute to IL-17 production in the lungs during RSV infection [19–
23, 27, 28]. Previous results have suggested that γδ T cells may contribute to early IL-17
Fig 8. γδ T cells are the primary source of exacerbated IL-17 production in an in vitromodel of BRDC. (A and B) PBMC from BRSV vaccinated cows
were stimulated with BRSV for 6 hours, then with 0.1 MOI of heat-inactivatedM. haemolytica (A) or 1 μg/mL purified LPS fromM. haemolytica (B). Control
cells remained unstimulated, were stimulated with only BRSV or were stimulated with only heat-inactivatedM. haemolytica LPS. After six days, cell culture
supernatants were analyzed by ELISA for IL-17. (C) PBMC from BRSV vaccinated cows were stimulated with BRSV for 6 hours, then cultured with 0.1 MOI
P.multocida in antibiotic free media for 4 hours. After four hours, antibiotics were added, and then incubations were continued for 6 days. Control cultures
were included that received neither pathogen, BRSV alone or P.multocida alone. Cell culture supernatants were analyzed by ELISA for IL-17. (D) PBMC
were depleted of γδ T cells using MACS. Total PBMC and γδ T cell-depleted PBMCwere then cultured in the presence of BRSV andM. haemolytica as
above. After 6 days, cell culture supernatants were analyzed by ELISA. Results in A-C are from one experiment with n = 4. Results in D are pooled from 2
independent experiments with n = 8. Data represent means ± SEM.
doi:10.1371/journal.pone.0151083.g008
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production, while Th17 cells are more important later in infection. On day 7 post-infection in
the calf, our results indicate that both cell subsets have the capacity for significant virus-specific
IL-17 production when isolated from peripheral blood. We were unable to detect BRSV-spe-
cific IL-17 production by peripheral blood lymphocytes at earlier time points after infection,
although possible IL-17 expression in the lungs at early time points was not examined. In
future studies, a more detailed analysis of the kinetics of IL-17 production by both cell types in
the blood and at the site of virus infection in the lungs will be valuable.
Currently, the extent of γδ T cell involvement in RSV disease in humans is poorly defined.
We have previously described potent chemokine and cytokine production by bovine γδ T cells
responding to in vitro and in vivo BRSV infection [30]; and we demonstrate here that γδ T cells
may play a critical role in IL-17 production during RSV infection in the calf. We suggest that
the bovine represents an excellent model for further delineating the role of γδ T cells in protec-
tion or immunopathology in the lungs during RSV infection. γδ T cells are conserved amongst
all vertebrate species, and are found in large proportions in a number of animal species includ-
ing cattle, sheep, pigs and poultry [47–50]. In young cattle, γδ T cells can comprise as high as
60% of circulating blood mononuclear cells, while the percentage in adult animals declines to
around 8–18% [47, 51]. The percentage of γδ T cells in humans is much smaller, ranging from
2–5% in healthy adults [52]. However, the frequency of γδ T cells circulating in human patients
with certain bacterial and protozoal infections can increase to as high as 57% of circulating
CD3+ T cells [52]. γδ T cells in both humans and cattle are hypothesized to play an immune
sentinel role, and large proportions are also found in the respiratory tract, mucosa and skin of
both species [53]. With the exception of their increased abundance in the bovine immune sys-
tem, literature suggests many similarities between bovine and human γδ T cells. Amongst
these, the ability to process and present antigens via MHC class II [54, 55], lack of MHC
restriction [53, 56], potent inflammatory chemokine and cytokine production [57], and innate
recognition of conserved pathogen associated molecular patterns via pattern recognition recep-
tors such as TLR and NLR [30, 57–61].
Studies in mice and humans have demonstrated production of IL-17 during acute infection
and recovery from BRSV. However, it remains debated if this response has positive or negative
consequences on the host. Some reports in children have suggested increased levels of IL-17 in
the BAL and plasma correlate with less severe RSV disease [19, 26]; while others have reported
the opposite [21]. In mice, it appears that IL-17 primarily contributes to immunopathology,
increased production of IL-13 and increased mucus production in the lungs [21, 23, 27, 28, 41];
although these effects vary depending upon the virus strain used. Importantly, conclusions
drawn from rodent models of RSV must be interpreted with caution, as it is clear that mice are
only semi-permissive to virus infection and do not reflect many aspects of disease pathogenesis
and immunity observed in RSV-infected children [3, 5, 6]. As a fully-permissive host for
BRSV, the calf model may be ideal for more clearly determining the role of IL-17 in immunity
to RSV infection, as well as elucidating the circumstances that contribute to a protective or
pathogenic role for IL-17.
Immunity in the lungs relies on a delicate balance between protective and pathogenic
inflammation. Thus, it is likely that some production of IL-17 may contribute to host protec-
tion, but an imbalance in this response can be damaging. The development of BRDC is not
clearly understood, but usually involves a primary viral infection leading to secondary bacterial
pneumonia [7, 9, 12, 62]. In a recent report, Li et al. used a mouse model to demonstrate that
primary influenza virus infection suppressed the production of IL-17 by murine γδ T cells,
leading to increased susceptibility to secondary bacterial infection with Streptococcus pneumo-
nia [63]. As a similar situation may be occurring in the calf with viral/bacterial co-infections,
we hypothesized that primary BRSV infection would impairM. haemolytica-induced IL-17
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production. In contrast, however, we observed significantly increased production of IL-17 in
cell cultures exposed to both BRSV andM. haemolytica together, compared to either pathogen
singly. It is important to note that our in vitro BRDC experiments were all carried out using
lymphocytes isolated from peripheral blood. It is currently unknown if similarly exacerbated
IL-17 production would be observed using cells isolated from the lungs, or during in vivo
BRSV/M. haemolytica co-infection. It is possible that lung-resident subsets of CD4 and γδ T
cells may respond differently to co-infection than cells from the blood, or that effects of the in
vivo lung microenvironment may alter IL-17 production and the inflammatory response. How-
ever, given the significant neutrophilia that is observed in calves with BRDC, our in vitro exper-
iments support the possibility that exacerbated IL-17 production, and hence exacerbated
neutrophil recruitment, may be occurring during in vivo infection. Thus, based upon results
from our in vitro coinfection model, we hypothesize that increased and exacerbated production
of IL-17 in the lungs may contribute to the unbalanced immune response and disease observed
in calves with BRDC, and suggest that γδ T cells may be critical to this outcome. In future
experiments, we plan to test this hypothesis and determine the contribution of IL-17 produc-
tion on disease pathogenesis in vivo in the BRDC affected calf.
M. haemolytica and P.multocida are closely related members of the family Pasteurellaceae
and common causes of the secondary bacterial pneumonia observed in calves with BRDC
[9,62]. Using our in vitro co-infection model of BRDC, we observed thatM. haemolytica infec-
tion resulted in exacerbated IL-17 production, while secondary infection with P.multocida did
not. Importantly, althoughM. haemolytica and P.multocida are in the same family, they are
genetically quite different and induce a different pathologic outcome in the infected host [8, 9].
In particular,M. haemolytica induces a more acute infection, while pneumonia caused by P.
multocida progresses more slowly. At this time we do not know the mechanism contributing to
exacerbated IL-17 during BRSV/M. haemolytica coinfection, nor is it clear why P.multocida
does not induce a similar response. One possible mechanism may be the action ofM. haemoly-
tica’s leukotoxin. Leukotoxin binds CD18 on ruminant leukocytes causing rapid, necrotic cell
death, and is hypothesized to play a role in the inflammation and neutrophilia observed in cat-
tle withM. haemolytica pneumonia [34]. P.multocida does not express leukotoxin [8, 9]. Fur-
ther analysis of differential immune responses induced by these two pathogens in vitro and in
vivomay contribute to our knowledge of host immunity and disease pathogenesis during
BRDC in the calf.
In conclusion, with this report, we have demonstrated for the first time the production of
IL-17, IL-21 and IL-22 in the calf with BRSV infection. We have also described a possible
mechanism for IL-17 leading to exacerbated inflammation that is commonly observed during
BRDC in the calf. Our results have implications for both children infected with RSV, and neo-
natal calves affected by respiratory disease. A more detailed analysis of the in vivo role of IL-17
in both contexts is critical to increase our understanding of disease pathogenesis for both RSV
and BRDC. Further studies may also implicate IL-17 and Th17 responses as a critical target for
therapeutic intervention in both children and cattle with RSV.
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